These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28382874)

  • 41. Psychotic disorders clinic and first-episode psychosis: a program evaluation.
    Archie S; Wilson JH; Woodward K; Hobbs H; Osborne S; McNiven J
    Can J Psychiatry; 2005 Jan; 50(1):46-51. PubMed ID: 15754665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. You say "schizophrenia" and I say "psychosis": Just tell me when I can come off this medication.
    Zipursky RB; Odejayi G; Agid O; Remington G
    Schizophr Res; 2020 Nov; 225():39-46. PubMed ID: 32115315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suicide attempts by jumping and psychotic illness.
    Nielssen O; Glozier N; Babidge N; Reutens S; Andrews D; Gerard A; Malhi GS; Large MM
    Aust N Z J Psychiatry; 2010 Jun; 44(6):568-73. PubMed ID: 20482416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder.
    Wong MM; Chen EY; Lui SS; Tso S
    Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):135-41. PubMed ID: 21983497
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.
    O'Donnell CP; Allott KA; Murphy BP; Yuen HP; Proffitt TM; Papas A; Moral J; Pham T; O'Regan MK; Phassouliotis C; Simpson R; McGorry PD
    J Clin Psychiatry; 2016 Dec; 77(12):e1610-e1617. PubMed ID: 27835719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brain volume change in first-episode psychosis: an effect of antipsychotic medication independent of BMI change.
    Jørgensen KN; Nesvåg R; Nerland S; Mørch-Johnsen L; Westlye LT; Lange EH; Haukvik UK; Hartberg CB; Melle I; Andreassen OA; Agartz I
    Acta Psychiatr Scand; 2017 Feb; 135(2):117-126. PubMed ID: 27925164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurocognition and Duration of Psychosis: A 10-year Follow-up of First-Episode Patients.
    Rund BR; Barder HE; Evensen J; Haahr U; ten Velden Hegelstad W; Joa I; Johannessen JO; Langeveld J; Larsen TK; Melle I; Opjordsmoen S; Røssberg JI; Simonsen E; Sundet K; Vaglum P; McGlashan T; Friis S
    Schizophr Bull; 2016 Jan; 42(1):87-95. PubMed ID: 26101305
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopamine D2-receptor affinity of antipsychotics in relation to subjective well-being in patients with a psychotic disorder.
    de Wit IE; van Dijk FA; Meijer CJ; van Tricht MJ; de Haan L;
    Int Clin Psychopharmacol; 2017 Sep; 32(5):249-255. PubMed ID: 28542034
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Twenty-year effects of antipsychotics in schizophrenia and affective psychotic disorders.
    Harrow M; Jobe TH; Tong L
    Psychol Med; 2022 Oct; 52(13):2681-2691. PubMed ID: 33550993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years.
    Álvarez-Jiménez M; Gleeson JF; Henry LP; Harrigan SM; Harris MG; Killackey E; Bendall S; Amminger GP; Yung AR; Herrman H; Jackson HJ; McGorry PD
    Psychol Med; 2012 Mar; 42(3):595-606. PubMed ID: 21854682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of 'all-cause discontinuation' of initial oral antipsychotic medication in first episode psychosis.
    Mustafa S; Joober R; Lepage M; Iyer S; Shah J; Malla A
    Schizophr Res; 2018 Nov; 201():287-293. PubMed ID: 29706449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Views of early psychosis clinicians on discontinuation of antipsychotic medication following symptom remission in first episode psychosis.
    Thompson A; Singh S; Birchwood M
    Early Interv Psychiatry; 2016 Aug; 10(4):355-61. PubMed ID: 25962446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Duration of untreated psychosis and acute remission of negative symptoms in a South American first-episode psychosis cohort.
    González-Valderrama A; Castañeda CP; Mena C; Undurraga J; Mondaca P; Yañez M; Bedregal P; Nachar R
    Early Interv Psychiatry; 2017 Feb; 11(1):77-82. PubMed ID: 26256570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of clinical remission following a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.
    Díaz I; Pelayo-Terán JM; Pérez-Iglesias R; Mata I; Tabarés-Seisdedos R; Suárez-Pinilla P; Vázquez-Barquero JL; Crespo-Facorro B
    Psychiatry Res; 2013 Apr; 206(2-3):181-7. PubMed ID: 23159063
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A cross-sectional observational study of healthcare professional views of factors affecting teenage adherence with antipsychotic medication.
    Ramdour S; Duxbury JA; Becket G; Wilson S
    J Psychiatr Ment Health Nurs; 2015 Sep; 22(7):491-501. PubMed ID: 25990303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prognostic significance of early remission of positive symptoms in first treated psychosis.
    Norman RM; Manchanda R; Windell D
    Psychiatry Res; 2014 Aug; 218(1-2):44-7. PubMed ID: 24780449
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical course of illness in women with early onset puerperal psychosis: a 12-year follow-up study.
    Kapfhammer HP; Reininghaus EZ; Fitz W; Lange P
    J Clin Psychiatry; 2014 Oct; 75(10):1096-104. PubMed ID: 25373118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Symptom Remission and Brain Cortical Networks at First Clinical Presentation of Psychosis: The OPTiMiSE Study.
    Dazzan P; Lawrence AJ; Reinders AATS; Egerton A; van Haren NEM; Merritt K; Barker GJ; Perez-Iglesias R; Sendt KV; Demjaha A; Nam KW; Sommer IE; Pantelis C; Wolfgang Fleischhacker W; van Rossum IW; Galderisi S; Mucci A; Drake R; Lewis S; Weiser M; Martinez Diaz-Caneja CM; Janssen J; Diaz-Marsa M; Rodríguez-Jimenez R; Arango C; Baandrup L; Broberg B; Rostrup E; Ebdrup BH; Glenthøj B; Kahn RS; McGuire P;
    Schizophr Bull; 2021 Mar; 47(2):444-455. PubMed ID: 33057670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors.
    Pérez-Iglesias R; Martínez-García O; Pardo-Garcia G; Amado JA; Garcia-Unzueta MT; Tabares-Seisdedos R; Crespo-Facorro B
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):41-51. PubMed ID: 24103107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine.
    Crespo-Facorro B; Pérez-Iglesias R; Mata I; Caseiro O; Martínez-Garcia O; Pardo G; Ramirez-Bonilla M; Pelayo-Terán JM; Vázquez-Barquero JL
    J Psychiatr Res; 2011 Jun; 45(6):763-9. PubMed ID: 21106207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.